Qilu Pharmaceutical Co., Ltd.
Clinical trials sponsored by Qilu Pharmaceutical Co., Ltd., explained in plain language.
-
New pill aims to tame stubborn high blood pressure
Disease control ENROLLING_BY_INVITATIONThis study tests a new medicine called QLS1410 for people whose high blood pressure stays high even with two or more drugs. About 260 adults will get either QLS1410 or a placebo pill for 12 weeks. The main goal is to see if the new pill lowers blood pressure more than the placebo…
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New hope for lung cancer patients with no standard target
Disease control OngoingThis study tests a new drug called QL1706 combined with chemotherapy for people with advanced non-small cell lung cancer that does not have a specific protein (PD-L1) or genetic mutations. About 606 adults will be randomly assigned to receive either QL1706 plus chemo or another d…
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 10:28 UTC
-
Healthy volunteers needed to compare two drugs in Early-Stage study
Knowledge-focused OngoingThis study tests a new drug called QL2106 against an approved drug, Tremfye®, in 190 healthy adults aged 18-45. The goal is to compare how the body processes each drug, their safety, and whether the body makes antibodies against them. Participants receive a single dose and are mo…
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 10:23 UTC
-
New fertility drug put to the test against Gonal-F
Knowledge-focused OngoingThis study tests a new fertility drug (QL1012D) against an approved one (Gonal-F) in 48 healthy women aged 18-45. The goal is to see if the new drug is absorbed and processed by the body similarly. Participants receive both drugs at different times, and researchers measure drug l…
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC